A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Regeneron Pharmaceuticals
- Study ID
- NCT06693531
- Status
- Recruiting
Conditions
- Eosinophilic Esophagitis (EoE)
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Year - N/A
- Healthy Volunteers
- Not accepted
Interventions
- dupilumab — DRUGNo investigational agents will be provided. Dupilumab will be prescribed as per usual clinical practice and will not be provided by the sponsor.
Study Details
This observational research study is to better understand patients with eosinophilic esophagitis (EoE) who have recently been prescribed DUPIXENT® (dupilumab). The purpose of this research study is to look at how DUPIXENT is used in normal care of patients with EoE. Possible benefits to others include a better understanding of EoE and helping to inform research and clinical trial design leading to treatment decisions in this patient population going forward. Patient questionnaires will measure the following: * How EoE makes one feel * EoE signs and/or symptoms, eg, how difficult it is to swallow * How EoE affects quality-of-life * How EoE impacts aspects of daily life * How EoE symptoms have changed throughout the study
Key Dates
- Start date
- Nov 22, 2024
- Status verified
- Apr 2026
- Primary completion
- May 22, 2030
- Completion
- May 22, 2030
Study Design
- Enrollment
- 350 participants (estimated)
Arms
- Arm: EoE Patients treated with DUPIXENT®
Primary Outcome Measure
Demographic characteristic of participants who receive dupilumab for EoE: Age [ Time Frame: Baseline and up to 3 years after treatment initiation ]
Central Contacts
- Clinical Trials Administrator844-734-6643
Locations (54)
Find similar trials in Phoenix, AZ
Related Studies
- Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral ImmunotherapyRecruiting · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania
- Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)PHASE4 · Recruiting · University of California, San Diego · La Jolla, California
- A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic EsophagitisPHASE3 · Recruiting · Regeneron Pharmaceuticals · Phoenix, Arizona
- Surface EMG Testing on Swallowing in EoE PatientsRecruiting · Mayo Clinic · Rochester, Minnesota